Sorry, you need to enable JavaScript to visit this website.

CYKLOKAPRON® (tranexamic acid) Indications and Usage

1 INDICATIONS AND USAGE

CYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for CYKLOKAPRON®